The ATM facility gives management discretion to sell shares into the market at any time, creating persistent overhang. Combined with the recent $57M private placement and authorized share count expansion to 10 billion, the dilution trajectory is severe. Monitor daily volume and any sales notices under the ATM for pace of dilution.
Price Chart
Executive Summary
Cenntro Inc. filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to $100 million of common stock through Pacific Century Securities, with a 3.5% commission. The filing follows a recent $57 million private placement in September 2026 and a massive authorized share increase from 3 billion to 10 billion shares approved by stockholders. The company has a history of losses, ongoing litigation, and significant China-related regulatory risks. The ATM offering adds further potential dilution to an already heavily diluted equity base.
Key Facts
- ATM offering of up to $100,000,000 of common stock via Pacific Century Securities at 3.5% commission.
- 17,585,452 shares outstanding pre-offering; pro forma 43,226,477 shares post-offering (assuming full sale).
- Closing price on Oct 8, 2026 was $3.90 per share; 52-week range $3.07 - $27.15 (post 1-for-60 reverse split).
- Recent $57,047,760 private placement of 15,120,000 shares at $3.773/share closed Sept 15, 2026.
- Authorized shares increased from 3 billion to 10 billion on Sept 24, 2026; reverse split ratio range expanded to 1-for-2,000.
- Net tangible assets per share pro forma as-adjusted after this offering: $4.22 (vs $11.60 historical as of June 30, 2026).
- PRC subsidiaries contributed 79% of consolidated net assets as of June 30, 2026; cash dividends never paid to holding company.
- Multiple pending litigations including a $19 million stock option claim and a $4.4 million lease dispute.
Financial Impact
Up to $100 million gross proceeds from ATM offering; net proceeds estimated at ~$96.3 million after fees. Combined with recent $57 million private placement, total equity raised in ~2 months could exceed $157 million.
Risk Factors
- Massive dilution from ATM offering plus recent private placement and authorized share increase.
- China regulatory risk: CSRC filing uncertainty, HFCA Act delisting risk, and restrictions on dividend repatriation.
- Going concern risk: history of operating losses, negative cash flow, and reliance on equity issuance for working capital.
- Nasdaq delisting risk: recent compliance regained but reverse split within 1 year limits future compliance options.
- Multiple pending litigations with material exposure (up to $19M claim).
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001140361-26-039383 |
| Document: 0001140361-26-039383-index-headers.html | 0001140361-26-039383 |
| Document: 0001140361-26-039383-index.html | 0001140361-26-039383 |
| Document: 0001140361-26-039383.txt | 0001140361-26-039383 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K/A | $2.48 | awaiting T+5 | — | $2.64 (+6.45%) |
Oct 15, 2026 11d ago | 8-K | $3.03 $2.34 | ▲ +22.77% | ▲ +22.34% | $2.64 (+12.87%) |
Oct 13, 2026 13d ago | 424B5 | $3.51 $2.53 | ▲ +27.92% | ▲ +26.77% | $2.64 (+24.79%) |
Sep 16, 2026 5w ago | 8-K | $4.62 $4.43 | ▲ +4.14% | ▲ +4.74% | $2.64 (+42.86%) |
Jun 5, 2026 20w ago | 8-K | $4.39 $4.01 | ▲ +8.66% | ▲ +10.77% | $2.64 (+39.86%) |
Apr 15, 2026 27w ago | 8-K | $3.84 $3.99 | ▲ +3.91% | ▲ +2.92% | $2.64 (−31.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers